低剂量与标准剂量光子计数CT评估肌病相关间质性肺病的可行性研究
低剂量方案CTDIvol仅0.77 mGy,各ILD模式的均值净差异均小于1%,与标准剂量一致性良好,且与肺功能指标的相关性相似。
要点
- 低剂量光子计数CT可显著降低辐射剂量,定量ILD模式与标准剂量高度一致。
- 网格影与FVC%和DLCO%强相关,低剂量与标准剂量相关性差异≤0.02。
- 超薄重建对支气管扩张的测量略高,但额外价值有限。
关键影像表现/征象
- 低剂量1.0mm重建较标准剂量轻度高估磨玻璃影体积(均值净差异0.98%),轻度低估纤维化范围(均值净差异-0.64%)。
- 超薄0.4mm重建在标准剂量扫描中测得支气管扩张体积略高(均值净差异0.13%)。
诊断标准与关键数值
- 低剂量与标准剂量各ILD模式的均值净差异均小于1%。
- 网格影与FVC%相关性rho=-0.62(p<0.001),与DLCO%相关性rho=-0.73(p<0.001),低剂量下相关性变化≤0.02。
临床应用与阅片要点
- 在IIM-ILD随访中可优先选用低剂量光子计数CT,以保证定量结果与标准剂量可比并降低辐射。
- 需注意低剂量可能轻微高估磨玻璃影、低估纤维化范围,报告时应结合临床谨慎解读。
局限性
- 缺乏纵向随访数据验证低剂量方案在疾病监测中的性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the clinical utility of photon counting computed tomography (PCCT)-derived quantitative parameters for assessing interstitial lung disease (ILD) burden in patients with inflammatory idiopathic myopathy (IIM), comparing standard-dose (SD) and tin-filtered low-dose (LD) protocols, and to assess the added value of ultrathin reconstructions.
MATERIALS AND METHODS: In this single-centre prospective study (September 2023-November 2024), outpatients with IIM-ILD underwent two consecutive PCCT scans. Quantitative ILD features were extracted using a commercial deep-learning software (ContextFlow ADVANCE Chest CT). Primary analyses compared LD 1.0 mm with SD 1.0 mm reconstructions using Bland-Altman analysis, with exploratory analyses of ultrathin (0.4 mm) reconstructions. Correlation analyses between deep learning-derived quantitative parameters, visual assessment, and pulmonary function tests were performed.
RESULTS: Forty-eight adults with IIM-ILD (40 females; mean age, 53.88 ± 11.13 years) were included. The LD protocol achieved a substantial dose reduction (CTDIvol: 0.77 vs 5.40 mGy) while maintaining good agreement with SD (mean net differences [MNDs] < 1% for all patterns). LD-1.0 mm protocol yielded higher volume of ground-glass opacity (MND, 0.98%) and lower volume of fibrosis extent (MND, -0.64%). Reticular pattern showed strong association with FVC% (rhoSD1.0mm = -0.62, p < 0.001) and DLCO% (rhoSD1.0mm = -0.73, p < 0.001), with similar correlations observed under LD acquisition (Δrho ≤ 0.02). Ultrathin reconstructions yielded greater measurement of bronchiectasis (MND, 0.13% on SD scans).
CONCLUSION: LD PCCT serves as a radiation-sparing alternative for quantitative disease assessment. Ultrathin reconstructions provide limited additional value. Future longitudinal studies are warranted to validate the performance of LD PCCT for disease monitoring.
KEY POINTS: Question Can LD photon-counting CT provide robust quantitative assessment of ILD burden in patients with inflammatory myopathy compared with SD imaging? Findings Deep learning segmentation yielded LD ILD patterns that closely matched SD results, with all MNDs below 1%. Clinical relevance LD PCCT maintains quantitative robustness and physiological validity for IIM-ILD assessment, with total disease burden showing good agreement with the SD protocol, offering a radiation-sparing alternative without compromising CT-physiology correlation.
引用
- Zhu Z, Xu K, Pang Y, et al. Low-dose vs standard-dose photon-counting CT for myopathy-associated interstitial lung disease: a prospective feasibility study. Eur Radiol. 2026. PMID: 42878810. doi:10.1007/s00330-026-12970-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。